Keystone exits Arbour

PharmaLex has acquired Chicago-based Arbour Group LLC, a provider of regulatory compliance solutions for the global life sciences industry.

PharmaLex has acquired Chicago-based Arbour Group LLC, a provider of regulatory compliance solutions for the global life sciences industry. The seller was Keystone Capital Inc. No financial terms were disclosed.

PRESS RELEASE

The PharmaLex Group (“PharmaLex”), a leading specialist provider of development consulting and scientific affairs, regulatory affairs and pharmacovigilance, has completed the acquisition of Arbour Group, LLC (“Arbour” or “the Company”) from Keystone Capital, Inc. (“Keystone”). Terms of the transaction were not disclosed.

Arbour is a leading provider of regulatory compliance solutions for the global life sciences industry. The Company is headquartered in Chicago, Illinois, and has sales offices throughout North America along with global regulatory delivery centers in Dubai, UAE and Manila, Philippines.

“Arbour Group is a well-recognized service provider with excellent reputation in the regulatory compliance market”, explained Dr Thomas Dobmeyer, CEO PharmaLex. “Their specialist expertise will enable us to drive business in the US whilst allowing us to expand our quality management and compliance service line worldwide. In addition it supports one of our key focus of developing connected health solutions to help customers drive efficiency gains within their own operations,” he added.

Senior management team members Alexander Patterson, Ahsan Raza, and Christopher McNally will be continuing in their current operating roles and as shareholders in Arbour post-closing. “The merger with PharmaLex provides Arbour the ability to deliver broad-spectrum regulatory and pharmaceutical service offerings, which our global customer base is demanding as their operating environments become increasingly complex,” noted Alexander Patterson, Founder and CEO of Arbour Group. “We are delighted to be partnered with an organization that shares the values and market reputation, which we have maintained with our customers throughout our 23-year history.”

“We are pleased with the outcome of the Arbour/PharmaLex transaction, as we believe that these organizations will be a terrific fit in a rapidly evolving industry. We wish both teams the best of luck with the combination,” noted Jason Van Zant, Managing Director, Keystone Capital.

Legal counsel was provided to Keystone and Arbour by Honigman Miller Schwartz and Cohn, LLP, and Fairmount Partners served as Keystone and Arbour’s financial advisor. McDermott Will & Emery LLP served as PharmaLex’s legal counsel, and Rödl Langford de Kock LLP provided tax and accounting advice.

About Keystone Capital
Keystone Capital, Inc. is a private investment firm based in Chicago, Illinois. Formed in 1994, its mission is to acquire and build a portfolio of exceptionally high quality, mid-sized businesses that are leaders in their niche markets. Keystone is differentiated by its investment of personal as opposed to third-party capital, which results in investment horizon flexibility and an ability to enter into true long-term operating partnerships with the professional management teams of its companies.